BC
TNDM icon

Bayforest Capital’s Tandem Diabetes Care TNDM Stock Holding History

Bayforest Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.2K Sell
3,792
-3,473
-48% -$60.6K 0.05% 587
2026
Q1 		$139K Sell
7,265
-20,144
-73% -$438K 0.16% 241
2025
Q4 		$602K Buy
27,409
+8,114
+42% +$146K 0.45% 12
2025
Q3 		$234K Buy
19,295
+10,024
+108% +$136K 0.11% 345
2025
Q2 		$173K Sell
9,271
-17,017
-65% -$337K 0.08% 407
2025
Q1 		$504K Buy
26,288
+17,436
+197% +$510K 0.22% 160
2024
Q4 		$319K Buy
+8,852
New +$299K 0.4% 30

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Bayforest Capital's TNDM Position: Q2 2026 in Review

Bayforest Capital reduced its Tandem Diabetes Care (TNDM) stake by 48% in Q2 2026, selling an estimated $60.6K and leaving 3,792 shares worth $57.2K. The position accounts for 0.05% of the portfolio, ranked #587.

Bayforest Capital first reported a position in TNDM in Q4 2024 and has held it in 7 quarters since. The position peaked at $602K in Q4 2025. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Bayforest Capital held 3,792 shares of Tandem Diabetes Care worth $57.2K as of Q2 2026.
  • Bayforest Capital sold 3,473 Tandem Diabetes Care shares in Q2 2026, an estimated $60.6K.
  • Tandem Diabetes Care made up 0.05% of Bayforest Capital's portfolio in Q2 2026, its #587 holding.
  • Bayforest Capital first reported a position in Tandem Diabetes Care in Q4 2024 and has held it in 7 quarters since.
  • Bayforest Capital's Tandem Diabetes Care position peaked at $602K in Q4 2025.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.